Get the Stockscreener App
0.7708
2.50%
0.0188
Pre-market:
.77
-0.0008
-0.10%
Evogene Ltd stock is traded at $0.7708, with a volume of 80,598.
It is up +2.50% in the last 24 hours and down -1.66% over the past month.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
See More
Previous Close:
$0.752
Open:
$0.7629
24h Volume:
80,598
Relative Volume:
0.18
Market Cap:
$9.33M
Revenue:
$3.95M
Net Income/Loss:
$-14.59M
P/E Ratio:
-0.663
EPS:
-1.1626
Net Cash Flow:
$-14.46M
1W Performance:
-1.81%
1M Performance:
-1.66%
6M Performance:
-34.68%
1Y Performance:
-33.55%
1-Day Range:
$0.7361
$0.795
1-Week Range:
$0.7361
$0.8199
52-Week Range:
$0.72
$2.42
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
0.7708 | 9.33M | 3.95M | -14.59M | -14.46M | -1.1626 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Jul-29-21 | Initiated | Aegis Capital | Buy |
| Dec-01-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-16-13 | Initiated | Oppenheimer | Outperform |
Evogene Ltd Stock (EVGN) Latest News
Evogene receives Nasdaq notification - MSN
Evogene files for resale of 5.08M shares via warrant exercise - MSN
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock (PR Newswire) - Aktiellt
EVGN (Evogene Ltd Ordinary Shares) posts far wider Q4 2025 per share loss than analyst estimates amid ongoing operational headwinds.Gamma Squeeze - Cổng thông tin điện tử tỉnh Lào Cai
Is Evogene (EVGN) stock worth starting a position in (Technical Weakness) 2026-04-20AI Powered Stock Picks - Cổng thông tin điện tử Tỉnh Sơn La
AI is rewiring future of energy crops – Ofer Haviv, CEO, Evogene - Agro Spectrum India
Gabi Tarcic Net Worth (2026) - GuruFocus
Polina Ravzin Net Worth (2026) - GuruFocus
Ilia Zhidkov Net Worth (2026) - GuruFocus
Evogene (EVGN) Stock: Breakout Signals (Underperforming) 2026-04-16Real-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
[EFFECT] Evogene Ltd. SEC Filing - Stock Titan
Yaron Eldad Net Worth (2026) - GuruFocus
Evogene Becomes Talk Of Retail Town As Stock Doubles On GenAI Drug, Agri Discovery Model With Google Cloud - MSN
What is driving long-term growth of Evogene (EVGN) Stock | Price at $0.79, Down 3.38%Stock Distribution - Cổng thông tin điện tử Tỉnh Sơn La
[Form 3] Evogene Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Macro Review: Is Evogene Ltd attractive for institutional investorsWeekly Gains Report & Risk Managed Investment Signals - baoquankhu1.vn
Movement Recap: Can Evogene Ltd disrupt its industry2026 Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Portfolio Recap: Is Evogene Ltd a play on infrastructure spending2026 Bull vs Bear & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Is Evogene (EVGN) Stock a Safe Investment | Price at $0.78, Down 0.15%Expert Momentum Signals - Xã Châu Thành
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance UK
Evogene receives Nasdaq delisting warning over share price By Investing.com - Investing.com Canada
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - Lelezard
Evogene reports receipt of Nasdaq minimum bid price notification - marketscreener.com
Evogene receives Nasdaq delisting warning over share price - Investing.com
Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026 - TipRanks
Evogene Gets Nasdaq Minimum Bid Price Notification - marketscreener.com
Nasdaq warns Evogene (NASDAQ: EVGN) over $1.00 minimum bid rule - Stock Titan
Evogene Ltd Stock: Pioneering AI-Driven Plant Genomics for Sustainable Agriculture Markets - AD HOC NEWS
Casterra reports successful castor farming trials in Brazil By Investing.com - Investing.com South Africa
Evogene Ltd. (EVGN) Stock Price, News, Quote & History - Yahoo Finance
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock - Finviz
Casterra reports successful castor farming trials in Brazil - Investing.com
Brazil field trials show castor oil can scale as a biofuel feedstock - Stock Titan
EVGN SEC FilingsEvogene 10-K, 10-Q, 8-K Forms - Stock Titan
Evogene Ltd Stock (EVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):